Contrast agents for applications including perfusion imaging
US9408927B2 · kind B2 · utility
12Cited by
41References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 27, 2009 |
| Grant date | Aug 9, 2016 |
| Priority date | — |
| Expiry date | Jul 13, 2030 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed, in part, to compounds and methods for imaging the central nervous system or cancer, comprising administering to a subject a contrast agent which comprises a compound that binds MC-I, and an imaging moiety, and scanning the subject using diagnostic imaging.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.